TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.1487
+0.0036 (2.48%)
Nov 17, 2026, 10:21 AM EST - Market open

TScan Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
73.04152.41178.69133.36120.03161.41
Short-Term Investments
--111.4258.69--
Cash & Short-Term Investments
73.04152.41290.11192.04120.03161.41
Cash Growth
-60.40%-47.47%51.06%60.00%-25.64%363.93%
Prepaid Expenses
3.754.82.612.194.14.25
Total Current Assets
76.78157.21292.72194.24124.13165.65
Property, Plant & Equipment
59.5166.4571.671.2369.217.26
Other Long-Term Assets
5.115.136.86.685.765.2
Total Assets
141.4228.79371.12272.15199.09188.11

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.241.244.282.372.911.77
Accrued Expenses
12.887.4715.3310.296.415.51
Current Portion of Long-Term Debt
15.7--3.35--
Current Portion of Leases
87.174.573.253.681.65
Current Unearned Revenue
-2.6211.710.143.8711.41
Other Current Liabilities
-0.20.080.430.431.01
Total Current Liabilities
37.8218.735.9629.8217.3121.34
Long-Term Debt
17.2732.5332.0726.729.29-
Long-Term Leases
48.354.4460.7459.1453.014.39
Long-Term Unearned Revenue
--1.255.62-1.5
Other Long-Term Liabilities
--0.14-0.050.1
Total Liabilities
103.39105.67130.15121.2899.6627.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.0100
Additional Paid-In Capital
634.98627.98616.01398.46257.81252.93
Retained Earnings
-596.97-504.86-375.1-247.6-158.38-92.16
Comprehensive Income & Other
--0.05---
Total Common Equity
38.01123.12240.97150.8799.43160.78
Shareholders' Equity
38.01123.12240.97150.8799.43160.78
Total Liabilities & Equity
141.4228.79371.12272.15199.09188.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
89.2894.1497.3892.4385.986.04
Net Cash (Debt)
-16.2458.27192.7399.6134.04155.36
Net Cash Growth
--69.77%93.48%192.60%-78.09%467.91%
Net Cash Per Share
-0.241.023.412.081.4213.32
Filing Date Shares Outstanding
67.7856.956.5947.8824.2323.86
Total Common Shares Outstanding
67.7856.956.5947.8324.2323.91
Working Capital
38.97138.51256.77164.42106.82144.31
Book Value Per Share
0.562.164.263.154.106.72
Tangible Book Value
38.01123.12240.97150.8799.43160.78
Tangible Book Value Per Share
0.562.164.263.154.106.72
Machinery
-24.7722.5918.6316.8712.15
Construction In Progress
-0.120.10.550.011.26
Leasehold Improvements
-5.393.263.163.453.43
SEC Filings: 10-K · 10-Q